Skip to main content
Top
Published in: Diabetologia 11/2003

01-11-2003 | Article

Identification of differentially expressed genes in skeletal muscle of non-diabetic insulin-resistant and insulin-sensitive Pima Indians by differential display PCR

Authors: Y. H. Lee, S. Tokraks, R. E. Pratley, C. Bogardus, P. A. Permana

Published in: Diabetologia | Issue 11/2003

Login to get access

Abstract

Aims/hypothesis

Whole body insulin resistance results largely from impaired insulin-stimulated glucose disposal into skeletal muscle. We carried out muscle gene expression profiling to identify differentially expressed genes associated with insulin resistance.

Methods

Skeletal muscle total RNA samples from six pairs of non-diabetic insulin-resistant and insulin-sensitive Pima Indians matched for percent body fat were analyzed by DDPCR with 90 primer combinations. The mRNA expression concentrations of selected 13 known genes and four expressed sequences tags were measured by quantitative real-time RT-PCR in 50 non-diabetic Pima subjects.

Results

From over 6500 displayed DDPCR cDNA bands, 36 of the most differentially expressed cDNAs were identified, revealing 29 unique sequences: 16 known genes, 10 expressed sequences tags and three unknown transcripts. Multiple regression analyses indicated that whole body insulin-mediated glucose disposal rates of the subjects, independent of age, sex, and percent body fat, were negatively correlated with mRNA concentrations of an EST (DD23; r=−0.38, p=0.007), ATP1A2 (r=−0.27, p=0.05), MAP2K4 (r=−0.34, p=0.02), and PRPSAP1 (r=−0.37, p=0.008). Transcript concentrations of DD23 (r=0.27, p=0.05) and MTND4 (r=−0.29, p=0.05) were correlated with plasma insulin concentration, independent of age, sex, and percent body fat.

Conclusion/interpretation

Altered expression concentrations of these genes might be causes or consequences of insulin resistance, and these genes serve as candidate susceptibility genes for insulin resistance.
Literature
1.
go back to reference Bogardus C (1996) Metabolic abnormalities in the development of non-insulin dependent diabetes mellitus. In: LeRoith D, Taylor SI, Olefsky JM (eds) Diabetes mellitus: a fundamental and clinical text. Lippincott Williams & Wilkins, Philadelphia, pp 459–467 Bogardus C (1996) Metabolic abnormalities in the development of non-insulin dependent diabetes mellitus. In: LeRoith D, Taylor SI, Olefsky JM (eds) Diabetes mellitus: a fundamental and clinical text. Lippincott Williams & Wilkins, Philadelphia, pp 459–467
2.
go back to reference Knowler WC, Bennett PH, Hamman RF et al. (1978) Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497–505PubMed Knowler WC, Bennett PH, Hamman RF et al. (1978) Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497–505PubMed
3.
go back to reference Lillioja S, Mott DM, Spraul M et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329:1988–1992PubMed Lillioja S, Mott DM, Spraul M et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329:1988–1992PubMed
4.
go back to reference Knowler WC, Pettitt DJ, Saad MF et al. (1991) Obesity in the Pima Indians: its magnitude and relationship with diabetes. Am J Clin Nutr 53:1543S–1551SPubMed Knowler WC, Pettitt DJ, Saad MF et al. (1991) Obesity in the Pima Indians: its magnitude and relationship with diabetes. Am J Clin Nutr 53:1543S–1551SPubMed
5.
go back to reference Hillier TA, Pedula KL (2001) Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 24:1522–1527PubMed Hillier TA, Pedula KL (2001) Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 24:1522–1527PubMed
6.
go back to reference Bogardus C, Lillioja S, Mott DM et al. (1985) Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 248:E286–E291PubMed Bogardus C, Lillioja S, Mott DM et al. (1985) Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 248:E286–E291PubMed
7.
go back to reference Lillioja S, Mott DM, Zawadzki JK et al. (1987) In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 36:1329–1335PubMed Lillioja S, Mott DM, Zawadzki JK et al. (1987) In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 36:1329–1335PubMed
8.
go back to reference DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15:318–368PubMed DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15:318–368PubMed
9.
go back to reference Yang X, Pratley RE, Tokraks S et al. (2002) Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians. Diabetologia 45:1584–1593CrossRefPubMed Yang X, Pratley RE, Tokraks S et al. (2002) Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians. Diabetologia 45:1584–1593CrossRefPubMed
10.
go back to reference Tataranni PA, Ravussin E (1995) Use of dual-energy X-ray absorptiometry in obese individuals. Am J Clin Nutr 62:730–734PubMed Tataranni PA, Ravussin E (1995) Use of dual-energy X-ray absorptiometry in obese individuals. Am J Clin Nutr 62:730–734PubMed
11.
go back to reference Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553PubMed Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553PubMed
12.
go back to reference Weyer C, Bogardus C, Mott DM et al. (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794PubMed Weyer C, Bogardus C, Mott DM et al. (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794PubMed
13.
go back to reference Bogardus C, Lillioja S, Howard BV et al. (1984) Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74:1238–1246PubMed Bogardus C, Lillioja S, Howard BV et al. (1984) Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74:1238–1246PubMed
14.
go back to reference Lillioja S, Bogardus C (1988) Obesity and insulin resistance: Lessons learned from the Pima Indians. Diabet Metab Rev 4:517–540 Lillioja S, Bogardus C (1988) Obesity and insulin resistance: Lessons learned from the Pima Indians. Diabet Metab Rev 4:517–540
15.
go back to reference Majer M, Mott DM, Mochizuki H et al. (1996) Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians. Diabetologia 39:314–321PubMed Majer M, Mott DM, Mochizuki H et al. (1996) Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians. Diabetologia 39:314–321PubMed
16.
go back to reference Liang P, Pardee AB (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967–971PubMed Liang P, Pardee AB (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967–971PubMed
17.
go back to reference Alway SE, Degens H, Lowe DA et al. (2002) Increased myogenic repressor Id mRNA and protein levels in hindlimb muscles of aged rats. Am J Physiol Regul Integr Comp Physiol 282:R411–R422PubMed Alway SE, Degens H, Lowe DA et al. (2002) Increased myogenic repressor Id mRNA and protein levels in hindlimb muscles of aged rats. Am J Physiol Regul Integr Comp Physiol 282:R411–R422PubMed
18.
go back to reference Higuchi E, Oridate N, Furuta Y et al. (2003) Differentially expressed genes associated with CIS-diamminedichloroplatinum (II) resistance in head and neck cancer using differential display and CDNA microarray. Head Neck 25:187–193CrossRefPubMed Higuchi E, Oridate N, Furuta Y et al. (2003) Differentially expressed genes associated with CIS-diamminedichloroplatinum (II) resistance in head and neck cancer using differential display and CDNA microarray. Head Neck 25:187–193CrossRefPubMed
19.
go back to reference Pratley RE, Thompson DB, Prochazka M et al. (1998) An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest 101:1757–1764 Pratley RE, Thompson DB, Prochazka M et al. (1998) An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest 101:1757–1764
20.
go back to reference Watanabe RM, Ghosh S, Langefeld CD et al. (2000) The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet 67:1186–1200PubMed Watanabe RM, Ghosh S, Langefeld CD et al. (2000) The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet 67:1186–1200PubMed
21.
go back to reference Lingrel JB (1992) Na,K-ATPase: isoform structure, function, and expression. J Bioenerg Biomembr 24:263–270PubMed Lingrel JB (1992) Na,K-ATPase: isoform structure, function, and expression. J Bioenerg Biomembr 24:263–270PubMed
22.
go back to reference Sweeney G, Klip A (1998) Regulation of the Na+/K+-ATPase by insulin: why and how? Mol Cell Biochem 182:121–133CrossRefPubMed Sweeney G, Klip A (1998) Regulation of the Na+/K+-ATPase by insulin: why and how? Mol Cell Biochem 182:121–133CrossRefPubMed
23.
go back to reference Nishida K, Ohara T, Johnson J et al. (1992) Na+/K(+)-ATPase activity and its alpha II subunit gene expression in rat skeletal muscle: influence of diabetes, fasting, and refeeding. Metabolism 41:56–63PubMed Nishida K, Ohara T, Johnson J et al. (1992) Na+/K(+)-ATPase activity and its alpha II subunit gene expression in rat skeletal muscle: influence of diabetes, fasting, and refeeding. Metabolism 41:56–63PubMed
24.
go back to reference Ng YC, Tolerico PH, Book CB (1993) Alterations in levels of Na(+)-K(+)-ATPase isoforms in heart, skeletal muscle, and kidney of diabetic rats. Am J Physiol 265:E243–E251PubMed Ng YC, Tolerico PH, Book CB (1993) Alterations in levels of Na(+)-K(+)-ATPase isoforms in heart, skeletal muscle, and kidney of diabetic rats. Am J Physiol 265:E243–E251PubMed
25.
go back to reference Russo JJ, Sweadner KJ (1993) Na(+)-K(+)-ATPase subunit isoform pattern modification by mitogenic insulin concentration in 3T3-L1 preadipocytes. Am J Physiol 264:C311–C316PubMed Russo JJ, Sweadner KJ (1993) Na(+)-K(+)-ATPase subunit isoform pattern modification by mitogenic insulin concentration in 3T3-L1 preadipocytes. Am J Physiol 264:C311–C316PubMed
26.
go back to reference Maier VH, Gould GW (2000) Long-term insulin treatment of 3T3-L1 adipocytes results in mis- targeting of GLUT4: implications for insulin-stimulated glucose transport. Diabetologia 43:1273–1281CrossRefPubMed Maier VH, Gould GW (2000) Long-term insulin treatment of 3T3-L1 adipocytes results in mis- targeting of GLUT4: implications for insulin-stimulated glucose transport. Diabetologia 43:1273–1281CrossRefPubMed
27.
go back to reference Berg CE, Lavan BE, Rondinone CM (2002) Rapamycin partially prevents insulin resistance induced by chronic insulin treatment. Biochem Biophys Res Commun 293:1021–1027CrossRefPubMed Berg CE, Lavan BE, Rondinone CM (2002) Rapamycin partially prevents insulin resistance induced by chronic insulin treatment. Biochem Biophys Res Commun 293:1021–1027CrossRefPubMed
28.
go back to reference Hanson RL, Ehm MG, Pettitt DJ et al. (1998) An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 63:1130–1138PubMed Hanson RL, Ehm MG, Pettitt DJ et al. (1998) An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 63:1130–1138PubMed
29.
go back to reference Vionnet N, Hani E, Dupont S et al. (2000) Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67:1470–1480PubMed Vionnet N, Hani E, Dupont S et al. (2000) Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67:1470–1480PubMed
30.
go back to reference Elbein SC, Hoffman MD, Teng K et al. (1999) A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 48:1175–1182PubMed Elbein SC, Hoffman MD, Teng K et al. (1999) A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 48:1175–1182PubMed
31.
go back to reference Seger R, Krebs EG (1995) The MAPK signaling cascade. FASEB J 9:726–735PubMed Seger R, Krebs EG (1995) The MAPK signaling cascade. FASEB J 9:726–735PubMed
32.
go back to reference Somwar R, Kim DY, Sweeney G et al. (2001) GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen- activated protein kinase. Biochem J 359:639–649CrossRefPubMed Somwar R, Kim DY, Sweeney G et al. (2001) GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen- activated protein kinase. Biochem J 359:639–649CrossRefPubMed
33.
go back to reference Guan Z, Buckman SY, Pentland AP et al. (1998) Induction of cyclooxygenase-2 by the activated MEKK1→SEK1/MKK4→p38 mitogen-activated protein kinase pathway. J Biol Chem 273:12901–12908PubMed Guan Z, Buckman SY, Pentland AP et al. (1998) Induction of cyclooxygenase-2 by the activated MEKK1→SEK1/MKK4→p38 mitogen-activated protein kinase pathway. J Biol Chem 273:12901–12908PubMed
34.
go back to reference Anderson S, Bankier AT, Barrell BG et al. (1981) Sequence and organization of the human mitochondrial genome. Nature 290:457–465PubMed Anderson S, Bankier AT, Barrell BG et al. (1981) Sequence and organization of the human mitochondrial genome. Nature 290:457–465PubMed
35.
go back to reference Antonetti DA, Reynet C, Kahn CR (1995) Increased expression of mitochondrial-encoded genes in skeletal muscle of humans with diabetes mellitus. J Clin Invest 95:1383–1388PubMed Antonetti DA, Reynet C, Kahn CR (1995) Increased expression of mitochondrial-encoded genes in skeletal muscle of humans with diabetes mellitus. J Clin Invest 95:1383–1388PubMed
36.
go back to reference Kita K, Ishizuka T, Ishijima S et al. (1994) A novel 39-kDa phosphoribosylpyrophosphate synthetase-associated protein of rat liver. Cloning, high sequence similarity to the catalytic subunits, and a negative regulatory role. J Biol Chem 269:8334–8340PubMed Kita K, Ishizuka T, Ishijima S et al. (1994) A novel 39-kDa phosphoribosylpyrophosphate synthetase-associated protein of rat liver. Cloning, high sequence similarity to the catalytic subunits, and a negative regulatory role. J Biol Chem 269:8334–8340PubMed
37.
go back to reference Wrischnik LA, Higuchi RG, Stoneking M et al. (1987) Length mutations in human mitochondrial DNA: direct sequencing of enzymatically amplified DNA. Nucleic Acids Res 15:529–542PubMed Wrischnik LA, Higuchi RG, Stoneking M et al. (1987) Length mutations in human mitochondrial DNA: direct sequencing of enzymatically amplified DNA. Nucleic Acids Res 15:529–542PubMed
38.
go back to reference Hertzberg M, Mickleson KN, Serjeantson SW et al. (1989) An Asian-specific 9-bp deletion of mitochondrial DNA is frequently found in Polynesians. Am J Hum Genet 44:504–510PubMed Hertzberg M, Mickleson KN, Serjeantson SW et al. (1989) An Asian-specific 9-bp deletion of mitochondrial DNA is frequently found in Polynesians. Am J Hum Genet 44:504–510PubMed
39.
go back to reference Schurr TG, Ballinger SW, Gan YY et al. (1990) Amerindian mitochondrial DNAs have rare Asian mutations at high frequencies, suggesting they derived from four primary maternal lineages. Am J Hum Genet 46:613–623PubMed Schurr TG, Ballinger SW, Gan YY et al. (1990) Amerindian mitochondrial DNAs have rare Asian mutations at high frequencies, suggesting they derived from four primary maternal lineages. Am J Hum Genet 46:613–623PubMed
Metadata
Title
Identification of differentially expressed genes in skeletal muscle of non-diabetic insulin-resistant and insulin-sensitive Pima Indians by differential display PCR
Authors
Y. H. Lee
S. Tokraks
R. E. Pratley
C. Bogardus
P. A. Permana
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 11/2003
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1226-1

Other articles of this Issue 11/2003

Diabetologia 11/2003 Go to the issue

Comment

Comment

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.